These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16493191)

  • 1. QT PRODACT: inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys.
    Sasaki H; Shimizu N; Suganami H; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):513-22. PubMed ID: 16493191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.
    Ando K; Hombo T; Kanno A; Ikeda H; Imaizumi M; Shimizu N; Sakamoto K; Kitani S; Yamamoto Y; Hizume S; Nakai K; Kitayama T; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):487-500. PubMed ID: 16493189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT PRODACT: usability of miniature pigs in safety pharmacology studies: assessment for drug-induced QT interval prolongation.
    Kano M; Toyoshi T; Iwasaki S; Kato M; Shimizu M; Ota T
    J Pharmacol Sci; 2005; 99(5):501-11. PubMed ID: 16493190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT PRODACT: inter- and intra-facility variability of the action potential assay using isolated guinea-pig papillary muscles.
    Yamazaki R; Yamada M; Kobayashi K; Kitani S; Shimada C; Shimosato T; Mori T; Suganami H; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):439-47. PubMed ID: 16493185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of drug-induced QT prolongation in a halothane-anesthetized monkey model: effects of sotalol.
    Ishizaka T; Yoshimatsu Y; Ozawa M; Kimotsuki T; Takasaki W; Manabe S; Yasuda M
    J Pharmacol Toxicol Methods; 2009; 59(2):86-93. PubMed ID: 19367688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT PRODACT: in vivo QT assay in anesthetized dog for detecting the potential for QT interval prolongation by human pharmaceuticals.
    Tashibu H; Miyazaki H; Aoki K; Akie Y; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):473-86. PubMed ID: 16493188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals.
    Toyoshima S; Kanno A; Kitayama T; Sekiya K; Nakai K; Haruna M; Mino T; Miyazaki H; Yano K; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):459-71. PubMed ID: 16493187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.
    Derakhchan K; Chui RW; Stevens D; Gu W; Vargas HM
    Br J Pharmacol; 2014 Jan; 171(2):509-22. PubMed ID: 24372552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation of QT shift in non clinical safety pharmacology studies.
    Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
    J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.
    Prior H; McMahon N; Schofield J; Valentin JP
    J Pharmacol Toxicol Methods; 2009; 60(2):167-73. PubMed ID: 19539041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects.
    Hess P; Rey M; Wanner D; Steiner B; Clozel M
    Lab Anim; 2007 Oct; 41(4):470-80. PubMed ID: 17988441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
    Vormberge T; Hoffmann M; Himmel H
    J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation.
    Chaves AA; Keller WJ; O'Sullivan S; Williams MA; Fitzgerald LE; McPherson HE; Goykhman D; Ward PD; Hoe CM; Mixson L; Briscoe RJ
    J Pharmacol Toxicol Methods; 2006; 54(2):150-8. PubMed ID: 16679034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys.
    Lynch JJ; Wilson AW; Hernandez LE; Nelson RA; Marsh KC; Cox BF; Mittelstadt SW
    Br J Pharmacol; 2008 Aug; 154(7):1439-45. PubMed ID: 18516073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT PRODACT: comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans.
    Omata T; Kasai C; Hashimoto M; Hombo T; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):531-41. PubMed ID: 16493193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.
    Mitchell AZ; Bills AJ; Wittwer GT; Foley CM; Kremer JJ; Chen H; Osinski MA
    J Pharmacol Toxicol Methods; 2013; 68(1):62-73. PubMed ID: 23639348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT PRODACT: sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation.
    Miyazaki H; Watanabe H; Kitayama T; Nishida M; Nishi Y; Sekiya K; Suganami H; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):523-9. PubMed ID: 16493192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
    Batey AJ; Doe CP
    J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT interval correction assessment in the anesthetized guinea pig.
    Morissette P; Regan HK; Fitzgerald K; Bernasconi S; Gerenser P; Travis J; Fanelli P; Sannajust F; Regan CP
    J Pharmacol Toxicol Methods; 2015; 75():52-61. PubMed ID: 26001325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.